“The best part of my day is when we find better ways to meet the needs of our customers and their patients.”

– Peter Karas

W

ith more than 25 years of commercial leadership experience in the pharmaceutical industry, Peter Karas has spearheaded business development, marketing, and sales for organizations all over the globe. From Xellia Pharmaceuticals to Baxter to Fresenius Kabi, Pete’s influence has built robust product portfolios and created successful teams. Joining Capstone in 2021, Pete is redefining the power of generic drugs—one reformulation at a time.